Lexaria Bioscience Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Intellectual Property

Intellectual Property

12 Months Ended

Aug. 31, 2022

Intellectual Property

Intellectual Property

9. Intellectual Property

The following is a list of capitalized US patents held by the Company.

Issued Patent #	Patent Certificate Grant Date	Patent Family
US 9,474,725 B1	10/25/2016	Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2	12/12/2017
US 9,972,680 B2	05/15/2018
US 9,974,739 B2	05/22/2018
US 10,084,044 B2	09/25/2018
US 10,103,225 B2	10/16/2018
US 10,381,440	08/13/2019
US 10,374,036	08/06/2019
US 10,756,180	08/25/2020
US 11,311,559	04/26/2022	Compositions and Methods for Enhanced Delivery of Antiviral Agents

Schedule of continuity for capitalized patents:

		August 31				August 31
		2022				2021
		$				$
Balance – Beginning			364,623				292,000
Addition			131,448				79,493
Amortization			(7,609	)			(6,870	)
Balance – Ending			488,462				364,623
Patents are amortized over their legal life of 20 years.